TY - JOUR
T1 - Anticoagulation therapy for atrial fibrillation in patients with implanted cardiac arrhythmia devices
AU - Ip, John H.
AU - Halperin, Jonathan L.
PY - 2011/12
Y1 - 2011/12
N2 - Atrial fibrillation (AF) is the most common arrhythmia requiring medical treatment. Atrial fibrillation and atrial flutter (AFl) are common cardiac arrhythmias associated with an increased incidence of stroke in patients with additional risk factors. The focus of this article, oral anticoagulation (OAC) therapy, reduces the risk of stroke. However, it is usually initiated after AF is documented on an electrocardiogram or after an ischemic event occurs.
AB - Atrial fibrillation (AF) is the most common arrhythmia requiring medical treatment. Atrial fibrillation and atrial flutter (AFl) are common cardiac arrhythmias associated with an increased incidence of stroke in patients with additional risk factors. The focus of this article, oral anticoagulation (OAC) therapy, reduces the risk of stroke. However, it is usually initiated after AF is documented on an electrocardiogram or after an ischemic event occurs.
KW - Atrial fibrillation
KW - Cardiac resynchronization device
KW - Implantable cardioverter-defibrillator
KW - Oral anticoagulation
KW - Remote monitoring
UR - http://www.scopus.com/inward/record.url?scp=82755189174&partnerID=8YFLogxK
U2 - 10.1016/j.ccep.2011.08.006
DO - 10.1016/j.ccep.2011.08.006
M3 - Review article
AN - SCOPUS:82755189174
SN - 1877-9182
VL - 3
SP - 631
EP - 639
JO - Cardiac Electrophysiology Clinics
JF - Cardiac Electrophysiology Clinics
IS - 4
ER -